BridgeMD
Tests treatment safety and results for Deglutition Disorders
Official title Clinical Trial on the Safety and Efficacy of Optimized Transcranial Direct Current Stimulation for the Swallowing Function in Patients With Post-Stroke Dysphagia
ClinicalTrials.gov ID: NCT06305949
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate whether the application of optimized transcranial direct current stimulation is more effective compared to sham stimulation for temporary improvement of swallowing function in patients with post-stroke dysphagia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- men and women \>19 years old
- patients with stroke confirmed by neuroimaging
- first-time stroke patients
- patients in subacute or chronic phases of stroke with 3 weeks or more after onset
- stroke patients with confirmed dysphagia through Videofluoroscopic Swallowing Study (VFSS).
You likely can't join if
- patients with recurrent stoke, traumatic brain injury, spine cord injury, and degenerative brain disease, such as Parkinson's disease, etc.
- patients with deteriorated cognitive function unable to perform the clinical trial as instructed
- patients with evidence of delirium, confusion, or other impairment of consciousness
- patients with uncontrolled medical disease or surgical conditions
- patients ineligible for Transcranial direct current stimulation (due to scalp condition, metallic material at the electrode attachment area, presence...
- patients with previous experience within the last year using a stimulation device similar to the one use in this clinical trial or who have...
See the full eligibility criteria
- men and women \>19 years old
- patients with stroke confirmed by neuroimaging
- first-time stroke patients
- patients in subacute or chronic phases of stroke with 3 weeks or more after onset
- stroke patients with confirmed dysphagia through Videofluoroscopic Swallowing Study (VFSS).
- patients with recurrent stoke, traumatic brain injury, spine cord injury, and degenerative brain disease, such as Parkinson's disease, etc.
- patients with deteriorated cognitive function unable to perform the clinical trial as instructed
- patients with evidence of delirium, confusion, or other impairment of consciousness
- patients with uncontrolled medical disease or surgical conditions
- patients ineligible for Transcranial direct current stimulation (due to scalp condition, metallic material at the electrode attachment area, presence of a pacemaker or cochlear implant)
- patients with previous experience within the last year using a stimulation device similar to the one use in this clinical trial or who have participated in related clinical trials
- patients with severe neurologic disorder with concomitant major psychiatric disorder such as major depressive disorder and dementia
- patients with history of uncontrolled epilepsy within 6 months
- patients with medical contraindications for neuroimaging test, such as MRI;
- patients who are taken contraindicated medications or require medication changes during the trial period that could influence cognitive/motor function changes via brain activation changes
- patients who are pregnant, breastfeeding, or planning pregnancy during the trial period
- patients considered medically ineligible for participation in the present trial beyond the criteria listened above.
The study team makes the final eligibility decision.
Where it's taking place
- Bucheon-si, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bucheon-si, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.